Showing 1 - 4 results of 4 for search 'Esteban Nogales‑Fernández', query time: 0.03s Refine Results
  1. 1
    Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial

    Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenal... by Carlos Jiménez-Cortegana, Pilar M. Sánchez-Martínez, Natalia Palazón-Carrión, Esteban Nogales-Fernández, Fernando Henao-Carrasco, Alejandro Martín García-Sancho, Antonio Rueda, Mariano Provencio, Luis de la Cruz-Merino, Víctor Sánchez-Margalet

    Published 2021-09-01
    Get full text
    Article
  2. 2
    Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

    Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer by Natalia Palazón‑Carrión, Carlos Jiménez‑Cortegana, M. Luisa Sánchez‑León, Fernando Henao‑Carrasco, Esteban Nogales‑Fernández, Massimo Chiesa, Rosalía Caballero, Federico Rojo, María‑Adoración Nieto‑García, Víctor Sánchez‑Margalet, Luis de la Cruz‑Merino, the Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA)

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

    Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer by Natalia Palazón-Carrión, Carlos Jiménez-Cortegana, M. Luisa Sánchez-León, Fernando Henao-Carrasco, Esteban Nogales-Fernández, Massimo Chiesa, Rosalía Caballero, Federico Rojo, María-Adoración Nieto-García, Víctor Sánchez-Margalet, Luis de la Cruz-Merino, the Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA)

    Published 2021-07-01
    Get full text
    Article
  4. 4
    CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

    CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma by Lourdes Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Daniel J. García-Domínguez, Natalia Palazón-Carrión, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, María L. Sánchez-León, Silvia Silva-Romeiro, Rocío Flores-Campos, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà-Padrò, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez-Carvajal, Jorge Labrador, María Guirado-Risueño, Mariano Provencio-Pulla, Margarita Sánchez-Beato, Lejeune Marylene, Tomás Álvaro-Naranjo, María Casanova-Espinosa, Antonio Rueda-Domínguez, Víctor Sánchez-Margalet, Víctor Sánchez-Margalet, Víctor Sánchez-Margalet, Luis de la Cruz-Merino, Luis de la Cruz-Merino, Luis de la Cruz-Merino

    Published 2024-02-01
    Get full text
    Article

Search Tools: